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Background&Aim: The immunopathogenesis of chronic hepatitis C virus (HCV) 
infection is a matter of great controversy. The imbalance of T-helper  lymphocyte 
cells cytokine production were believed to play an important pathogenic role in 
chronic viral hepatitis. Occult hepatitis C infection is regarded as a new entity that 
should be considered when diagnosing patients with a liver disease of unknown 
origin. The aim of this study was to determine serum T-helper 1 and T-helper 2 
cytokine production in patients with occult HCV infection and its role in its 
pathogenesis versus chronic viral hepatitis C infection. 
Methods: Serum levels of cytokines of T-helper 1 (IL-2, IFN-γ) and T-helper 2 (IL-4) 
were measured in 27 patients with occult HCV infection and 50 patients with chronic 
hepatitis C infection. 
Results:  The levels of the T-helper 1 cytokines, IL-2 and IFN-γ, were highly 
significant increased in patients with chronic HCV infection as compared with occult 
HCV infection (p < 0.001). The T-helper 2 cytokine IL-4 was highly significant 
increased in occult HCV infection as compared with chronic HCV infection (p < 
0.001). Necroinflammation (P <0.001) fibrosis (P <0.001) and cirrhosis (P =0.03) 
were significantly increased in chronic HCV than occult HCV.  
Conclusion: Patients with occult HCV infection exhibited a distinct 
immunoregulatory cytokine patterns; favoring viral persistence in the liver in spit of 
its absence from peripheral blood and explaining the less aggressive course of this 
disease entity than chronic hepatitis C virus infection.  
Key words: Occult HCV, Chronic hepatitis C, Cytokines. 
Introduction: 
  Hepatitis C virus (HCV) is a commonly encountered pathogen in 
medical practice. It is estimated that 2-3% of the world is affected by 
HCV, with a prevalence of 170 million people (3% of the world's 
population) and incidence of 3-4 million per year (1). Chronic HCV 
infection is a progressive disease that may lead to liver cirrhosis and 
hepatocellular carcinoma. The hallmark of chronic hepatitis C is the 
presence of anti-HCV and HCV RNA in serum for more than 6 months 
after acute infection (2, 3). 
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  Recently a new form of HCV infection called occult HCV infection has 
been described. Occult HCV infection is defined by the presence of 
HCV-RNA in liver cells but with undetectable anti-HCV and serum viral 
RNA. Patients with occult HCV infection have abnormal liver function 
tests and 35% of them have histological damage, including liver cirrhosis 
(4).  
 Histological evaluation of the liver biopsies of patients with occult HCV 
infection documented different degrees of necroinflammatory activity and 
fibrosis (including cirrhosis) as reported for  chronic hepatitis C (5).  
  Patients with occult HCV infection presents a milder disease than 
patients with chronic hepatitis C. The low number of infected hepatocytes 
found in patients with occult HCV infection may be related with less liver 
damage. Furthermore, immune response of these patients may be fine-
tuned better than that of patients with chronic hepatitis C, leading to a 
more effective control of the infection (6).  
 There is suggestive evidence that T-cell immunoregulatory cytokines 
may play a key role in influencing the persistence of HCV infection and 
the extent of liver damage (7-11). Activated CD4+ T cells can be divided 
into 2 subsets based on their cytokine secretion profiles (12-14). The T 
helper type 1 (Th1) subset produces interferon-gamma (IFN-γ), tumor 
necrosis factor alpha (TNF-α , and interleukin (IL)-2, and participates in 
cell-mediated immune responses (13, 14); the T helper type 2 (Th2) 
subset produces IL-4 and IL-10, and mediates humoral immune responses 
(15). The Th1/Th2 cytokine balance is likely important in determining the 
rate of HCV infection chronicity and HCV-induced liver injury (16,17). 
  The aim of this work is to study the Th1/Th2 cytokine profiles in 
patients with occult HCV infection versus patients with chronic hepatitis 
C. 
Materials and Methods: 
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 A total of 27 out of 45 untreated patients with elevated transaminases of 
unknown etiology were proved to be occult HCV infection (HCV-RNA 
in liver as detected by reverse transcriptase-polymerase chain reaction 
(RT-PCR) and by in situ hybridization, but anti-HCV and serum HCV-
RNA were negative) were included in this study. The Cytokine patterns, 
biochemical and histological characteristics of these patients were 
compared with those of a group of 50 untreated anti-HCV and serum 
HCV-RNA-positive patients with histologically proved chronic hepatitis 
C matched to age, gender, estimated duration of abnormal liver function 
tests and body mass index (BMI) to avoid statistical differences that 
could affect the characteristics of the disease. All patients attending the 
outpatient clinic of Tropical Medicine Unit, Mansoura University 
Hospital during the period from June 2007 to December 2009.  
  All known causes of liver diseases were excluded on the basis of 
analytical, clinical, and epidemiological data: infection by HBV (i.e., 
subjects were negative for hepatitis B surface antigen and for serum 
HBV-DNA), autoimmunity, metabolic and genetic disorders, NASH, 
alcohol intake, and drug toxicity and all cases were negative for anti-HIV 
antibodies. RT PCR was performed to detect HCV RNA in hepatocytes 
of all patients with occult HCV.  
The study was conducted following the guidelines of the 1975 
Declaration of Helsinki, and all patients gave their written informed 
consent to participate in it. 
Samples: 
1. Cytokines assay:  From each patient two ml venous blood was 
collected into    clean dry plastic  tube and allowed to clot, the yielded 
serum was used for quantitative detection of IL-2, IL-4 and IFN-γ serum 
levels which were measured with enzyme-linked immunosorbent assay 
(ELISA) kits (Bender      Med Systems,  Vienna, Austria). 
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2. Liver biopsy 
    The patients underwent an ultrasound-guided liver biopsy (using Tru-cut 
needles) for diagnostic purposes. Liver biopsy specimens were divided into 
2 portions. One portion was fixed in 10% formalin and was paraffin 
embedded for routine histological diagnosis. Histological evaluation was 
performed by a pathologist who was blinded with respect to the HCV RNA 
status of the liver biopsy specimens. Necroinflammatory activity and 
fibrosis were scored according to the METAVIR score system (18,19). A 
minor (4–5mm to make an average weight of 15-20mg) fragment of the 
specimen, was immediately immersed in dry ice until extraction of RNA in 
the lab within minutes The extracted RNA was immediately reverse 
transcribed and stored at -20°C until used for detection of HCV RNA by 
RT-PCR. 
2.1. Preparation of liver cell lysate for total RNA isolation 
    The amount of tissue was determined by weighing (all samples weighed 
20mg each) according to the recommendation of NORGEN Biotek 
corporation (ON, Canada). Tissues were then slowly ground while still in 
dry ice. Then 600 µl of lysis solution was added to the tissue samples and 
grinding was continued until homogenization of the samples. 
Homogenization was insured by passing the lysate 5-10 times through a 25 
gauge needle attached to a syringe. Lysate was then transferred to an 
RNase-free microfuge tube and spun down for 2 minutes to pellet any cell 
debris. Supernatant was then transferred to another RNase-free microfuge 
tube and an equal volume of 70% ethanol was added and vortexed for 
proper mixing. 
2.2. Total RNA extraction and purification 
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    Lysate (600 µl) with ethanol from the previous step was applied to the 
assembled column and collection tube and centrifuged for 1 minute. The 
flowthrough was discarded and the spin column and collection tube was 
reassembled and the process was repeated until the lysate finishes. After 
this 400 µl of wash solution was added to the column and centrifuged for 
one minute, the flowthrough was discarded and the process repeated twice.  
Then RNA was eluted by adding 50 µl of elution buffer to the column and 
centrifugation for a minute. The purified RNA was immediately reverse 
transcribed into cDNA and stored at -20oC until used for PCR. 
3. Blood samples 
    Blood samples for separating peripheral blood mononuclear cells 
(PBMCs) were collected from all patients on the same day that the liver 
biopsy was performed. PBMC were obtained by Ficoll-Hypaque density 
gradient of EDTA anti-coagulated blood according to the manufacturer's 
instructions (Lymphoflot, Biotest, 63303 Dreleich, Germany). Cells were 
washed three times with Mg2+- and Ca2+-free PBS and resuspended to 
1x106 cell ml–1 in PBS. 
3.1. Peripheral-blood mononuclear cell lysate for total RNA isolation 
    Up to 100µl of PBMCs suspension in PBS was transferred to an RNase-
free microfuge tube. To them was added 350 µl of lysis solution, cells were 
then lysed by vortexing for 15 seconds (or until the mixture becomes clear). 
After this 200 µl of 95% ethanol was added to the lysate and mixed by 
vortexing for 10 seconds. The lysate was used for RNA extraction 
following the same protocol for liver cell lysate. 
REVERSE TRANSCRIPTION AND NESTED PCR 
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    The synthesis of cDNA and the two PCR rounds were performed using 
oligonucleotide primers from the highly conserved 5  untranslated region 
(UTR) of the genome; external primers [P1 (sense, -
GCGACACTCCACCATAGAT-; nucleotides 10–28) and P4 (antisense, -
ACTCGCAAGCACCCTATCA-; nucleotides 303–285)] for the first-
round PCR and internal primers [P2 (sense, -
CTGTGAGCAACTACTGTCT-; nucleotides 36–55) and P3 (antisense, -
CGGTGTACTCACCGGTTCC-; nucleotides 161–143)] for the second-
round PCR (20).  
    Amplification of the cDNA was performed using 15 μL of the cDNA 
solution and 50 pmol of the outer primers (P1 and P4). Thirty cycles of 
DNA amplification were carried out, followed by an extension step for 
10 min at 72°C.  Each cycle of PCR consisted of 95 °C for 45 s, 50 °C for 
45 s and 72°C for 45 s. The second PCR was carried out in the same way 
with 5 μL of the first PCR mixture and 50 pmol of each inner primer (P2 
and P3). The amplified DNA was visualized by 2% agarose gel 
electrophoresis and ethidium bromide staining. The size of the second 
product generated by PCR was 126 bp. 
    All PCR assays were performed according to the recommendations of 
Kwok and Higuchi (21).  
    Furthermore, several negative controls (no-RNA) were included in each 
PCR step, to assure the specificity of the results. 
Statistical analysis: 
    The statistical analysis of data done by using excel program and SPSS 
program statistical package for social science version 10. The description 
of the data done in form of mean (+/-) SD for quantitative data and 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.6
65
4.
1 
: P
os
te
d 
29
 N
ov
 2
01
1
 8
frequency & proportion for qualitative data.  The analysis of the data was 
done to test statistical significant difference between groups. For 
quantitative date student t-test was used to compared between 2 gp paired 
sample t-test was used to compare one gp at different measurements.  A 
2-tailed P value <0.05 was considered to denote statistical significance. 
Results:  
  Table (1) showed characteristics of patients with occult HCV infection 
and those with chronic hepatitis C infection where no significant 
difference regarding age, gender and BMI was observed. Significant 
increase were found in classic HCV than occult HCV infection regarding 
bilirubin (P <0.001), ALT (P =0.009), AST (P =0.013), AFP (P <0.001), 
while serum albumin was significantly higher in occult HCV than chronic 
HCV (p <0.001). 
Table (2) showed histological characteristics of both studied groups. 
Hepatic necroinflammation (P <0.001) fibrosis (P <0.001) and cirrhosis 
(P =0.03) were significantly increased in chronic HCV than occult HCV.  
Table (3) showed the Th1/Th2 cytokine patterns of the studied patients, 
groups. The levels of the Th1 cytokines, IL-2 and IFN-γ, were increased 
in patients with chronic HCV infection versus those with occult HCV 
infection (p < 0.001). The Th2- cytokine, IL-4 was significantly increased 
in occult HCV infection versus those with chronic HCV infection (p < 
0.001).  
Discussion: 
   Several studies have suggested that T-cell immunoregulatory 
cytokines play a key role in both HCV viral persistence and in 
the extent of liver damage, while some cytokines may exert a 
pro-inflammatory activity, such as IFN-α, IL-8, TNF-α and IL-
2, which can prime T-cells towards a Th-1 type immunity, 
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others have a predominantly anti-inflammatory activity, as is the 
case for IL-4 and IL-10, which are involved in Th-2 immunity. 
Some of these cytokines may have a fibrogenic (e.g., TGF-β) or 
an antifibrogenic (e.g., IFN-α) role (22). Some authors have 
suggested that a preferential shift towards either Th1 or Th2 
response may influence the clinical outcome and disease 
progression (23-27). Patients with occult HCV infection present 
a milder disease than patients with chronic hepatitis C (6). 
The aims of the present study were (1) to evaluate the Th1/Th2 cytokine 
profiles in patients with occult HCV infection  compared to chronic HCV 
infection patients, and (b) to clarify the histological characteristics of  
occult HCV infection  versus chronic HCV infection patients.  
   This study demonstrated that there was a significant increase 
in Th1 cytokine IL-2 and IFNγ in patients with chronic HCV 
infection compared to the occult HCV infection. This significant 
shift of cytokine pattern in chronic HCV towards Th1 pattern 
more than occult HCV infection may suggest that, the clinical 
and histological differences observed between occult and 
chronic hepatitis C may be a consequence of the hosts 
immunological system and its derived cytokines as shift of 
cytokine towards Th1 is associated with more progression of 
disease. These data are supported by the following. The 
expression of some cytokines is more closely related to the 
severity of the disease. IFN-γ is clearly augmented in the serum 
of chronic hepatitis C patients (28-30) and its increase has been 
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correlated with an increase in the severity of disease (31). In 
contrast of our result Pham et al found that, PBMC from 
individuals with occult infection transcribed significantly greater 
levels of IFN-α, IFN-γ and TNF-α, but less interleukin (IL)-10 
than those from CHC ( 32). IL-2 is considered to be a Th1 type 
cytokine and is involved in enhancing the proliferation and 
activation of most T lymphocytes, NK cells and B-lymphocytes. 
Liver sinusoidal and inflammatory cells have been reported to 
be sources of IL-2 and no consensus exists on the predictive 
value of this cytokine. Apparently, expression of IL-2 is 
associated with a more advanced stage of disease, as previously 
reported (33-35). Napoli et al in 1996 (23) demonstrated that, as 
liver injury worsens there is an increase in intrahepatic Th1-like 
cytokine m RNA levels. In particular there was a positive 
correlation between IFN- γ and IL-2 mRNA expression and the 
severity of both the inflammatory (portal tract) and fibrotic 
components. In contrast to our suggestion of the responsibility 
of predominance of Th1 cytokines (IFN- γ and IL-2) about the  
high degree of histological activity in chronic HCV than occult 
HCV is that of Abayli et al  who found no difference in the 
serum levels of IFN-γ between patients with chronic HCV 
infection and normal controls. On the other hand, Th2 cytokines, 
IL-4 and IL-10, were found to be higher in patients with chronic 
HCV infection than in healthy controls. None of the cytokines 
was correlated with the histological activity score (36).  
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  Our data show a significant increase in serum IL-4 in patients 
with occult HCV infection in comparison to chronic HCV 
infection. IL-4 is a 15- KD protein that has been shown to 
regulate a wide spectrum of function of B cells, monocytes/ 
macrophages and other non-haematopoietic cells (37). Among T 
cells clones. IL-4 is produced by Th0 and Th2 cells, but not by 
Th1, and this now been demonstrated both in mice and humans 
(38). Beside T cells, mast cells and basophils can produceIL-4 
and mRNA for IL-4 has been found in eosinophils (39). 
  Increased level of Th2 cytokineIL-4 may be responsible for the 
decrease in IFN-γ and IL-2 production among occult HCV 
infection in the present study. This finding is concordant with 
other study (36) who found that, Th2 cytokines regulate the 
antibody secretion by B cells and have suppressor functions. 
Increased levels of Th2 cytokines, IL-4 and IL-10, may be 
responsible for the decrease in IFN-γ production.  
  In spit of less aggressive course of occult HCV and absent of 
HCV-RNA in peripheral blood the body immune system can not 
eradicate the infection. This could possibly be due to 
predominant Th2 IL-4 in occult HCV that is may be responsible 
for persistence of infection in patients with occult HCV. These 
could be supported by reports from other authors which 
proposed that the inability to terminate HCV infection may 
result from the inappropriate release of some T-cell and 
monocytemacrophage derived cytokines, such as interleukin 
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(IL-4) and IL10 (40, 41). These cytokines may inhibit cellular 
mediated antiviral responses by interfering with T cell activation 
and function (42 45).  
  Undetectable serum HCV-RNA in case of occult HCV 
infection can explain the low level of Th1 cytokines in our study 
among occult infection than chronic HCV infection. The 
existence of a relationship between chronic HCV replication and 
Th1 predominance was further supported by the finding of 
marked decrease in the Th1 response in patients in whom the 
HCV-RNA titre dropped to undetectable levels following IFN-α 
abolishing the antigenic stimulus to derive a Th1 response. This 
could also explain the apparent contradiction that IFN- α, which 
has been reported to promote development of Th1 cells (46-47), 
induced a strong reduction of Th1 cells in vivo. 
In conclusion: Occult HCV infection has predominant Th2 
cytokine pattern that may responsible for viral persistent in the 
liver in spit of its absence from peripheral blood. Lack of Th1 
cytokine response in occult HCV may explain the less 
aggressive course of occult HCV than chronic HCV infection. 
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Table (1): Characteristics of patients with occult HCV infection and those 
with chronic hepatitis C: 
 Occult HCV 
(n=27) 
Chronic HCV 
(n=50) 
P-value 
Age/ye 49.96±2.64 51.07±2.55         0.07 
Albumin (gm/dL) 4.05±0.07 3.69±.0..25 <0.001 
Bilirubin(mg/dl) 0.8±.0.15 1.2±0.29 <0.001 
ALT (u/L) 54.4±14.7 62.1±10.5 0.009 
AST (u/L) 50.6±13.3 57.4±9.7 0.013 
AFP(ng/mL) 4.3±1.7 13.5±4.3 <0.001 
 
Table (2): Histological characteristics of patients with occult HCV 
infection and Classic chronic hepatitis C. 
 Occult HCV 
(n=27) 
Chronic HCV 
(n=50) 
P-value 
Necroinflammation 10 (37%) 50 (100%) <0.001 
Fibrosis 6 (22.2%) 40 (80%) <0.001 
Cirrhosis 1 (3.7%) 11 (22%) 0.03 
 
Table 3: Th1/Th2 cytokine patterns of occult and chronic HCV infection. 
Cytokines Occult HCV Chronic HCV P value 
IL2  (pg/L) 102.1±6.7 193.6±15.4 < 0.001 
IFNγ (pg/L) 28.6±4.2 64.8±6.76 < 0.001 
IL4 (pg/L) 120.3±9.2 68.9±2.15 < 0.001 
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